A former director of Greenpeace UK called GMO opposition “morally unacceptable.”

A new synthetic drug manufactured in China is surging in popularity in South Florida. A glimpse into our future?

Multimillion dollar breach shows Putin’s cyber tactics at work. The Germans may not be interested in rivalry with Russia, but Russia is interested in rivalry with them.

In Iraq, is failing to plan planning to fail?

S&P and Moody’s are talking a little more stridently as the Greek standoff grinds on.

Delegates are struggling to whittle down a bloated draft text ahead of the Paris climate summit, and time is running out.

The Egyptian economy has recovered from attacks against tourism sites before. But now, Egypt can ill-afford a spate of violent attacks against one if its most vital industries.

Gazprom needs another six weeks to mount a response to EU anti-trust charges. The stakes are high.

Russia uses fighter jets and navy ships to threaten NATO forces as they hold exercises in the Baltic. Is Putin making a dangerous mistake?

Greece’s creditors warn they’ve reached the end of the line. But are the creditors credible?